mitoquinol: Clinical Trials

6 trials of mitoquinol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting, 1 terminated. 3 Phase 1, 3 Phase 2, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 23Completed 2, Terminated 1
Early Phase 11Active not recruiting 1
Not applicable1Active not recruiting 1

Follow mitoquinol: new trials by email Literature Review of mitoquinol trials Research Report on mitoquinol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MitoQ and Exercise Effects on Vascular Health
MitoQ, Placebo, Aerobic exercise - Aging, Menopause
Early Phase 1Active not recruitingUniversity of Colorado, Denver222023-01-162025-03-25
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
MitoQ, Placebo - Aging
Phase 2CompletedUniversity of Colorado, Boulder1122021-04-022026-08-05
MitoQ for Fatigue in Multiple Sclerosis (MS)
20 mg MitoQ, Placebo, 40mg of MitoQ - Multiple Sclerosis, Fatigue
Phase 1 / Phase 2CompletedVA Office of Research and Development452020-04-012026-04-24
MitoQ for the Treatment of Metabolic Dysfunction in Asthma
Mitoquinol, Placebo oral tablet - Asthma, Obesity
Phase 1CompletedUniversity of Vermont472020-01-012025-12-11
MitoQ for Fatigue in Multiple Sclerosis
Mitoquinone, Placebo - Multiple Sclerosis, Fatigue
Phase 1 / Phase 2TerminatedOregon Health and Science University92018-09-152023-04-05
Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF
Acute Antioxidant, Chronic Antioxidant, Placebo - Cystic Fibrosis
Not applicableActive not recruitingAugusta University132015-04-012025-01-28

Conditions studied

Fatigue (2)  ·  Multiple Sclerosis (2)  ·  Asthma (1)  ·  Cystic Fibrosis (1)  ·  Motor Activity (1)  ·  Obesity (1)

Sponsors

Augusta University (1)  ·  Oregon Health and Science University (1)  ·  University of Colorado, Boulder (1)  ·  University of Colorado, Denver (1)  ·  University of Vermont (1)  ·  VA Office of Research and Development (1)

Countries

United States (6)

Top investigators

Anne E Dixon, MD (1)  ·  Douglas R Seals (1)  ·  Kerrie L Moreau, PhD (1)  ·  Ryan Harris, Ph.D. (1)  ·  Vijayshree Yadav, MBBS (1)  ·  Vijayshree Yadav, MD (1)

Results publications

PMID 36187760, PMID 41264372

NIH funding

R01AG066730 (1), R56AG072094 (1)